These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 36707911)

  • 1. Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma.
    Zhang J; Gao J; Hu M; Xu S; Cheng C; Zheng W; Zhang J
    Eur J Med Res; 2023 Jan; 28(1):46. PubMed ID: 36707911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA modification writers pattern in relation to tumor microenvironment and prognosis in prostate cancer.
    Cheng X; Yi X
    Front Genet; 2022; 13():1065424. PubMed ID: 36744180
    [No Abstract]   [Full Text] [Related]  

  • 5. RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance.
    Zhao H; Zhou Q; Shi C; Shao Y; Ni J; Lou J; Wei S
    Med Sci Monit; 2021 Oct; 27():e930994. PubMed ID: 34690344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 and Immune Infiltration of m
    Lin Y; Yao Y; Wang Y; Wang L; Cui H
    Biomed Res Int; 2021; 2021():5516100. PubMed ID: 34055974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
    Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma.
    Yin T; Zhao L; Yao S
    BMC Med Genomics; 2022 Mar; 15(1):53. PubMed ID: 35260168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma.
    Zhang S; Xiong Y; Zheng C; Long J; Zhou H; Zeng Z; Ouyang Y; Tang F
    Front Cell Dev Biol; 2022; 10():821678. PubMed ID: 35155433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer.
    Gao W; Chen D; Liu J; Zang L; Xiao T; Zhang X; Li Z; Zhu H; Yu X
    Front Immunol; 2022; 13():1031184. PubMed ID: 36601127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.
    Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y
    Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.
    Ni X; Chen C; Cui G; Ding W; Liu J
    Front Immunol; 2022; 13():932876. PubMed ID: 35837397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation regulator-based molecular subtyping and tumor microenvironment characterization in hepatocellular carcinoma.
    Zhao J; Liu Z; Yang K; Shen S; Peng J
    Front Immunol; 2024; 15():1333923. PubMed ID: 38736884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Non-N
    Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
    Front Immunol; 2021; 12():809808. PubMed ID: 35154083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The m
    Ma E; Li J; Shen C; Gu Y; Zhang X; Li L; Zhao J; Wang Z
    Front Immunol; 2023; 14():1227593. PubMed ID: 37691948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Multi-Layer RNA Modification Patterns for the Characterization of Tumor Immune Microenvironment in Hepatocellular Carcinoma.
    Xing J; Shen S; Dong Z; Hu X; Xu L; Liu X; Li Q; Zhang Y; Cui G; Yu Z
    Front Cell Dev Biol; 2021; 9():761391. PubMed ID: 34858985
    [No Abstract]   [Full Text] [Related]  

  • 18. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma.
    Zhao M; Shen S; Xue C
    Front Immunol; 2022; 13():805967. PubMed ID: 35401564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma.
    Li W; Wu R; Zhang S; Zhao Y; Li L; Hu Z; Su Q; Mang Y; Zhang X; Dong Y; Zheng K; Ran J; Li L
    Clin Transl Oncol; 2023 Jul; 25(7):2099-2115. PubMed ID: 36708372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma.
    Xu Y; Liao W; Luo Q; Yang D; Pan M
    Front Immunol; 2022; 13():761046. PubMed ID: 35145517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.